Glenmark Pharma and SaNOtize announce Peer Reviewed Publication of its Phase 3 Clinical Trials on SaNOtize's Novel Nitric Oxide Nasal Spray

The study demonstrated that patients who received NONS had significant reduction in viral load within 24 hours, which was sustained over seven days of treatment.

Bajaj Healthcare forays into the highly regulated - Opiate Processing Business for the GOI

The company plans to execute both these tenders at their API manufacturing unit located at Savli, Gujarat, India.

Athos announces research collaboration to advance precision medicine in inflammatory bowel disease

Athos will perform multi-omic molecular and genetic analyses using biopsies from archived and de-identified Lahey IBD patient samples

W.R. Grace to expand capacity at small-molecule API plant

The expansion at CDMO facility in South Haven, will bring a new 4,000-gallon multi-use reactor train consisting of glass lined and stainless-steel materials of construction

Heathcare startup MedTel to raise around USD 10mn in Series A

MedTel aims to raise series A for rapid business expansion, product improvement & conducting relevant clinical validation studies.

SRL Diagnostics launches fatty liver index

An algorithm based testing for Fatty Liver Disease

Eversana partners with Compai Pharma to expand commercialisation services across APAC

EVERSANA and Compai Pharma will provide medical and commercial resources to healthcare partners

Piramal Pharma Solutions holds opening ceremony for new API Plant at Aurora, Canada

Plant is part of the company's CAD $30 million capital investment in the site

Biosyntia closes 1.5 million EUR round to launch world’s first bio-based vitamin B7

The round was closed with an investment from the European Circular Bioeconomy Fund (ECBF) and the two existing investors, Sofinnova Partners and Novo Seeds

Healthcare Triangle announces $6.5 million private placement